Researchers saw significant increases in testosterone levels for men with obesity or Type 2 diabetes while taking GLP-1 medications, The Hill wrote. Also in the news: vaping, PFAS, junk food, and more ...

HabitNu, a CDC-recognized digital health company focused on lifestyle change for diabetes, obesity, and chronic disease prevention, has been selected by the Centers for Medicare & Medicaid Services ...

Cancer deaths related to obesity have tripled in the United States over the past 20 years, according to new research ...

Susan Monarez is the first director of the Centers for Disease Control and Prevention to require Senate confirmation. She's ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

According to recent estimates by the Centers for Disease Control and Prevention, nearly one in five children in the United ...